IMC Chicago’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Sell
45,300
-21,200
-32% -$124K ﹤0.01% 4699
2025
Q4
$476K Sell
66,500
-28,300
-30% -$201K ﹤0.01% 3518
2025
Q3
$716K Buy
94,800
+11,000
+13% +$80.3K ﹤0.01% 2944
2025
Q2
$523K Buy
83,800
+13,500
+19% +$62.5K ﹤0.01% 2834
2025
Q1
$219K Sell
70,300
-24,200
-26% -$85K ﹤0.01% 3033
2024
Q4
$373K Sell
94,500
-48,800
-34% -$171K ﹤0.01% 2889
2024
Q3
$580K Buy
+143,300
New +$500K ﹤0.01% 2343

Other funds holding EVLV

IMC Chicago's EVLV Position: Q1 2026 in Review

IMC Chicago reduced its Evolv Technologies (EVLV) stake by 79% in Q1 2026, selling an estimated $290K and leaving 13,337 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5400.

IMC Chicago first reported a position in EVLV in Q3 2024 and has held it in 6 quarters since. The position peaked at $451K in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • IMC Chicago held 13,337 shares of Evolv Technologies worth $80.7K as of Q1 2026.
  • IMC Chicago sold 49,608 Evolv Technologies shares in Q1 2026, an estimated $290K.
  • Evolv Technologies made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5400 holding.
  • IMC Chicago first reported a position in Evolv Technologies in Q3 2024 and has held it in 6 quarters since.
  • IMC Chicago's Evolv Technologies position peaked at $451K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.